A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, I. 1977

M M Amin, and T A Ban, and H E Lehmann

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010868 Pimozide A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to HALOPERIDOL for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. (From AMA Drug Evaluations Annual, 1994, p403) Antalon,Orap,Orap forte,R-6238,R6238
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder

Related Publications

M M Amin, and T A Ban, and H E Lehmann
July 1977, Psychopharmacology bulletin,
M M Amin, and T A Ban, and H E Lehmann
January 1974, Acta psychiatrica Scandinavica. Supplementum,
M M Amin, and T A Ban, and H E Lehmann
July 1977, Psychopharmacology bulletin,
M M Amin, and T A Ban, and H E Lehmann
July 1977, Psychopharmacology bulletin,
M M Amin, and T A Ban, and H E Lehmann
January 1974, Acta psychiatrica Scandinavica. Supplementum,
M M Amin, and T A Ban, and H E Lehmann
September 1974, Current therapeutic research, clinical and experimental,
M M Amin, and T A Ban, and H E Lehmann
April 1972, International journal of clinical pharmacology, therapy and toxicology,
M M Amin, and T A Ban, and H E Lehmann
November 1971, Current therapeutic research, clinical and experimental,
M M Amin, and T A Ban, and H E Lehmann
July 1974, Current therapeutic research, clinical and experimental,
M M Amin, and T A Ban, and H E Lehmann
September 1970, Current therapeutic research, clinical and experimental,
Copied contents to your clipboard!